The White House coordinator for combating the spread of the new coronavirus, Jeff Zients, said that the United States would distribute about 60 million doses of the vaccine.
The United States is considering making available to other states all of its stocks of the coronavirus vaccine created by the British-Swedish company AstraZeneca. White House Press Secretary Jen Psaki announced this on Monday at a regular briefing for journalists.
“The [US] administration is exploring options to provide [authorities in other countries] with doses of the US-made AstraZeneca vaccine in the next few months,” she said.
“Given the strong portfolio of vaccines that [the US authorities] have already approved [for use] and which are available in large volumes, < … > and given that [the company’s drug] AstraZeneca is not approved for use in the US, we do not need to use in the next few months in our fight against [the coronavirus disease] COVID-19 [the vaccine] AstraZeneca,” Psaki said.
She assured that experts of the US government would study the question of whether this vaccine is safe. “Before any AstraZeneca [vaccine] doses are shipped from the United States, the Food and Drug Administration [under the U.S. Department of Health and Human Services] will confirm that such doses meet product quality expectations. This is done in the context of the department’s study of all the doses produced at the facility that produces [in the US] all the doses of AstraZeneca,” Psaki said. She also clarified that the United States currently does not have a single ready-made dose of the drug from AstraZeneca. “Just to be clear, we have zero available doses right now,” Psaki said. As she explained, experts of the US administration expect that at the end of the process of studying the vaccine, the mentioned office will be available “approximately 10 million doses”. This could happen “in the coming weeks,” the spokeswoman predicted. Moreover, approximately in May – June in the United States, Psaki said, is expected to be released about 50 million more doses of the AstraZeneca vaccine. “We are currently in the planning process,” the White House representative added. She confirmed that the US authorities would then study the “range of requests” from other states, “the range of needs around the world.”